Article info

other Versions

PDF
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Authors

  1. Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org
View Full Text

Citation

Kay J, Schoels MM, Dörner T on behalf of the Task Force on the Use of Biosimilars to Treat Rheumatological Diseases, et al
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Publication history

  • Received June 15, 2017
  • Revised July 20, 2017
  • Accepted August 12, 2017
  • First published September 2, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.